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PPOH and DDMS, inhibitors of the epoxygenase and v-hy-Arachidonic acid directly activates members of the mitogen-
droxylase pathways, respectively, failed to significantly reduceactivated protein kinase superfamily in rabbit proximal tubule
the effects of arachidonic acid to activate ERK and p38MAPKcells.
(JNK was not evaluated). Finally, arachidonic acid, its inactiveBackground. To explore the roles of eicosanoids in arachi-
analog ETYA, and other fatty acids with differing chain lengthsdonic acid-induced mitogen-activated protein kinase (MAPK)
signal transduction, we have shown that exposure of proximal and degrees of saturation stimulated the activity of all three
tubular cells to arachidonic acid induces phosphorylation of MAPKs.
c-Jun NH2-terminal kinase (JNK) and extracellular signal-regu- Conclusions. These observations substantiate a role for ara-
lated kinase (ERK), two members of the MAPK superfamily. chidonic acid and other fatty acids in signaling linked to the
We observed that ketoconazole, an inhibitor of the cytochrome MAPK superfamily in rabbit proximal tubular epithelium with-
P450 pathway, blocked ERK but not JNK activation. out the necessity of conversion to cytochrome P450 metabo-
Methods. Direct regulation of arachidonic acid on mitogen- lites.
activated protein kinase (MAPK) signaling pathways was eval-
uated more directly by utilizing specific enzyme inhibitors of
the cytochrome P450 metabolic pathway and by comparing the
As subgroups of the mitogen-activated protein kinaserelative efficacy of arachidonic acid versus its cytochrome P450
metabolites (exogenous and endogenous), eicosatetraynoic acid (MAPK) superfamily, c-Jun, NH2-terminal kinase (JNK),
(ETYA), and other fatty acids on the phosphorylation of mem- and p38MAPK were initially found to be activated by stress
bers of the MAPK superfamily (ERKs, JNK, and p38MAPK), by stimulations such as ultraviolet (UV) exposure, osmoticutilizing early passage rabbit proximal tubular epithelial cells.
shock, and oncoproteins and pro-inflammatory cytokinesResults. Arachidonic acid activated p38MAPK, a third member
[for example, tumor necrosis factor (TNF) and interleu-of the MAPK superfamily, in a time- and concentration-depen-
dent manner. Studies designed to evaluate the ability of arachi- kin-1(IL-1)] [1–5], whereas the extracellular signal-regu-
donic acid and its cytochrome P450 metabolites (endogenously lated kinases (ERKs; p44MAPK and p42MAPK) are activated
and exogenously) to stimulate ERKs, JNK, and p38MAPK found by growth factors and mitogenic stimuli [6]. All threefour conclusions. First, the metabolites of arachidonic acid gener-
members of this superfamily have been implicated inated endogenously by cytochrome P450 2C1 significantly aug-
such cellular events as cell death, growth, and differentia-mented basal ERK activity, whereas the metabolites generated
by the 2C2 isozyme significantly augmented basal p38MAPK activ- tion, thus indicating a broad role for the MAPK in cell
ity. However, their effects were less profound than arachidonic biology. The mechanisms of activation of MAPK super-
acid itself. In contrast, there were no significant effects with family are summarized in Figure 1.transfection of either isozyme on basal JNK activity. Second,
Extracellular signal-regulated kinase, JNK, and p38MAPKa variety of exogenous cytochrome P450 products were less potent
were found to be activated by G-protein–coupled recep-than arachidonic acid on a molar basis in stimulating the activity
of all three MAPKs. Third, ketoconazole and 17-octadecynoic tors (GPCRs), including angiotensin II (Ang II) [7–11].
acid, inhibitors of the cytochrome P450 pathway, as well as In rabbit proximal tubular epithelial cells, Ang II activa-
tion of the MAPK superfamily is mediated by arachi-
donic acid following activation of an apical angioteinsinKey words: eicosanoids, cytochrome P450, signal transduction, ketoco-
nazole, c-Jun NH2-terminal kinase, extracellular signal-regulated kinase. II subtype 2 (AT2) receptor subtype and a membrane-
associated phospholipase-A2 (PLA2) [8, 12, 13]. StudiesReceived for publication May 18, 2000
from this laboratory have documented a novel mecha-and in revised form December 11, 2000
Accepted for publication December 15, 2000 nism of Ang II-induced ERK phosphorylation involving
tyrosine phosphorylation of the epidermal growth factorÓ 2001 by the International Society of Nephrology
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Fig. 1. Mechanisms of activation of the mitogen-activated protein kinase (MAPK) superfamily. The MAPK superfamily includes the extracellular
signal-regulated kinase (ERK; p44MAPK and p42MAPK), c-Jun NH2-terminal kinase (JNK), and p38MAPK. These kinases are directly phosphorylated
by upstream kinases referred to as MAP kinase kinases (MAPK kinases; MEK and MKK). MEK 1/MEK 2 are the major upstream activators of
ERKs, whereas SEK1/MEKK4 and MKK3/MKK6 phosphorylate the JNK/SAPK and p38 MAPK pathways, respectively. The MAPK kinases are
themselves regulated by upstream kinases referred to as MAP kinase kinase kinases (MAPKKK or MEKKs). Raf preferentially activates the
ERK pathway, whereas activation of the JNK/SAPK and p38MAPK pathways occur via direct phosphorylation of MEKK1-MEKK3. Whereas the
small GTP-binding protein Ras controls the activation of ERKs, JNK and p38MAPK activation is regulated by the small GTPases, Rac and Cdc42.
JNK and p38MAPK were initially found to be activated by stressor stimulation such as ultraviolet (UV) exposure and osmotic shock, and have been
implicated in such cellular events as programmed cell death (apoptosis), proliferation, hypertrophy, and inflammation. ERKs are activated by
growth factors and various hormones and play a major role in events such as cell mitogenesis and differentiation.
(EGF) receptor, its association with the adaptor protein ERK induced by arachidonic acid, whereas the inhibitor
of the cytochrome P450 isozymes, ketoconazole, and theShc, formation of Shc/Grbs2/Sos complex, activating the
small guanosine triphosphate (GTP) binding protein lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA)
abolished ERK phosphorylation induced by arachidonicp21ras and ERK phosphorylation [7, 14]. Arachidonic
acid mimics the effects of this GPCR and appears to acid [8]. In contrast, none specifically inhibited arachi-
donic acid-induced JNK activation [15]. The specificitymediate this AT2 signaling paradigm. Arachidonic acid
activates JNK through activation of NADPH oxidase, of ketoconazole and NDGA effects is questionable, given
that our unpublished data demonstrate that when thebut independently of protein kinase C (PKC) [15].
Our previous studies were aimed at exploring the role epithelial cells are maintained in culture, there is negligi-
ble epoxyeicosatrienoic acid (EET) and hydroxyepoxy-of eicosanoids in arachidonic acid-induced ERK and
JNK activation and were limited to the use of relatively eicosatrienoic acid (HETE) production as detected by
high-pressure liquid chromatography (HPLC). Thesecrude inhibitors of cyclooxygenase, lipoxygenase, and
cytochrome P450 pathways. The cyclooxygenase inhibi- observations raised concerns about the specificity of
these inhibitors, and the inability of ketoconazole totor indomethacin had no effect on phosphorylation of
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distinguish between the v-hydroxylase and epoxygenase scribed [16] and maintained in standard growth media,
Dulbecco’s modified Eagle’s medium (DMEM)/Ham’senzymatic pathways, the two major isozymes of the cyto-
chrome P450 mono-oxygenase pathway. Therefore, the F-12 (1:1), supplemented with 15 mmol/L HEPES buffer
(pH 7.4), 0.35 mg/mL l-glutamine, 0.6 mg/mL sodiumpresent study addressed this question more directly by
comparing the relative efficacy of arachidonic acid, its bicarbonate, 100 U/mL penicillin, 100 mg/mL streptomy-
cin, 5 mg/mL bovine insulin, 5 mg/mL human transferrin,cytochrome P450 metabolites (exogenous and endoge-
nous), its inactive analogue eicosatetraynoic acid (ETYA), 0.5 mmol/L hydrocortisone, and 5% fetal bovine serum
(FBS). Cells were grown on 75 cm2 Costar Petri dishesand other fatty acids on the phosphorylation of three
members of the MAPK superfamily (ERK, JNK, and as subconfluent monolayers.
p38MAPK) by using rabbit proximal tubular epithelial cells
Arachidonic acid metabolismmaintained short-term in tissue culture.
To our knowledge, this is the first study to report First-passage proximal tubule cells were transfected
at 60 to 70% confluence with 10 mg plasmid DNA con-that cytochrome P450 isozymes 2C1 and 2C2 metabolize
arachidonic acid to products that activate various mem- taining the full-length cDNAs for P450 2C1 [17] or 2C2
[18, 19] in pCMV5 (provided by Dr. Byron Kemper,bers of the MAPK superfamily in proximal tubule cells.
However, direct effects of arachidonic acid are suggested University of Illinois, Carbondale, IL, USA) using Lipo-
fectAMINE Plus Reagent (GIBCO/BRL) and grown onin that it is more potent when compared with exogenous
or endogenous P450 products and fatty acids, including 100 mm Costar culture dishes in standard growth me-
dium for 18 hours and subsequently serum restrictedthe inactive analogue of arachidonic acid, ETYA.
for 24 hours. For mock transfection, the pCMV5 vector
without the cDNA inserts was employed. Cells were
METHODS
incubated in serum-free media containing 1.5 mmol/L
Chemicals arachidonic acid and 1 mmol/L [14C]-arachidonic acid
(0.5 mCi, 55 mCi/mmol) for two hours. The media wereArachidonic acid was purchased from ICN Pharma-
ceuticals (Costa Masa, CA, USA). Myelin basic protein removed, and fresh serum-free growth media were
added. The cells were preincubated either with or with-(MBP), anti-rabbit IgG agarose beads, rabbit anti-pig
antibody (whole molecule), and fatty acids (linoleic, lin- out 30 mmol/L of the cytochrome P450 inhibitor ketoco-
nazole at 378C for 30 minutes, and then in the presenceolenic, oleic, palmitoleic, stearic, and arachidic) were
purchased from Sigma (St. Louis, MO, USA). [Sar1]-Ang or absence of 15 mmol/L arachidonic acid for five min-
utes. The media were once again removed, and the cellsII was obtained from Peninsula Laboratories (Belmont,
CA, USA). Cell culture medium and additives and Lipo- were lyzed in 2 mL of 15% ethanol, pH 3.5, with formic
acid. The samples were scraped into an ice-cold glassfectAMINE Plus Reagent were purchased from GIBCO/
BRL (Grand Island, NY, USA). Ketoconazole, 17-octa- culture tube and were extracted twice with 2 mL ethyl
acetate and subsequently dried under nitrogen gas. Eachdecynoic acid (17-ODYA), and ETYA were obtained
from Biomol (Plymouth Meeting, PA, USA). [g32P]-ATP, sample was dissolved in 40 mL of ethanol, and metabo-
lites were separated by reverse-phase HPLC on a Micro-[3H]-arachidonic acid, and [14C]-arachidonic acid were
purchased from Dupont/NEN (Boston, MA, USA). Re- sorb-MV C-18 (4.6 mm 3 5.0 cm) column (Rainin,
Woodburn, MA, USA) using a linear gradient rangingcombinant ATF-2 and rabbit anti-JNK1 (FL), anti-ERK1
(C-16), and anti-p38 MAP kinase (C-20) polyclonal anti- from acetonitrile/water/acetic acid (50:50:0.1) to acetoni-
trile/acetic acid (100:0.01) at a flow rate of 1.3 mL/minbodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Rabbit polyclonal anti-phos- for 35 minutes. Arachidonic acid and its metabolites
were detected by monitoring radioactivity using a Beck-pho-p44MAPK/p42MAPK and anti-phospho-p38MAPK antibod-
ies were obtained from New England Biolabs (Beverly, man 171 Radioisotope Detector (Beckman, Palo Alto,
CA, USA). The percentage of radiolabeled metabolitesMA, USA). Epoxygenase inhibitor, 6-(2-propargyloxy-
phenyl)hexanoic acid (PPOH), and v-hydroxylase inhib- generated was calculated from peak surface area.
itor, N-methylsulfonyl-12,12-dibromododec-11-enamide
Kinase assays(DDMS), epoxides (5,6-EETs, 8,9-EETs, 11,12-EETs,
and 14,15-EETs), and omega hydroxides (19-HETEs and For the ERK assay, cells were extracted with lysis
buffer [50 mmol/L Tris/HCl (pH 7.6), 150 mmol/L NaCl,20-HETEs) were generous gifts from Dr. John R. Falck
(University of Texas Southwestern Medical Center, Dal- 0.5% sodium deoxycholate (wt/vol), 1% NP-40 (IGEPAL
CA-630; vol/vol), 1% Triton X-100 (vol/vol), 1 mmol/Llas, TX, USA).
Na3VO4, 1 mmol/L egtazic acid (EGTA), 0.2 mmol/L
Isolation of rabbit renal proximal tubule and cell culture phenylmethylsulfonyl fluoride, 1 mmol/L NaF, 25 mg/mL
leupeptin, 10 mg/mL pepstatin, and 10 mg/mL aprotinin].Primary culture of proximal tubule cells were isolated
from male New Zealand white rabbits as previously de- One hundred micrograms of whole cell extracts from
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unstimulated and stimulated cells were precleared by hicle. At the end of the incubation periods, the incuba-
tion medium was removed and transferred to ice-coldincubation with 1 mg/mL of nonimmune rabbit IgG and
30 mL of goat anti-rabbit IgG agarose beads on a rotating tubes. The tubes were then centrifuged at 13,000 r.p.m.
for five minutes to eliminate cell debris. To determineplate for 1.5 hours at 48C. After preclearing cell lysates,
supernatants were incubated overnight on a rotating the level of radioactivity in the supernatant, 0.5 mL of
each sample was placed in a scintillation vial, and theplate at 48C with 1 mg of a polyclonal anti-ERK1 anti-
body and 25 mL of goat anti-rabbit IgG agarose beads. radioactivity in the medium was quantitated by liquid
scintillation spectrometry (Beckman Co.).The activity was determined by phosphorylation of 4 mg
MBP in 20 mmol/L HEPES (pH 7.6), 20 mmol/L MgCl2,
Statistics analysis20 mmol/L ATP, 5 mCi [g32P]ATP, and 2 mmol/L dithio-
threitol. The kinase reaction was terminated after 15 The results are expressed as means 6 SEM from com-
bined experiments. The data were evaluated by one-wayminutes at 308C by the addition of Laemmli’s sample
buffer (60 mL) followed by boiling for five minutes. The analysis of variance (ANOVA) followed by the New-
man–Keuls multiple comparison test or by paired t testphosphorylation of the substrate protein was examined
after sodium dodecyl sulfate-polyacrylamide gel electro- when appropriate. The limit of significance was a P value
#0.05.phoresis (SDS-PAGE) by exposure to autoradiography.
The bands were subsequently cut from the gel and
counted for radioactivity. Protein contents were deter-
RESULTS
mined by bicinchoninic acid assay.
Arachidonic acid activates p38MAPK in a time- andJNK and p38MAPK activity were analyzed following im-
dose-dependent manner involving MKK3/MKK6munoprecipitation with anti-JNK1(FL) and anti-p38MAPK
(1-20) polyclonal antibodies, respectively, employing Previously, we demonstrated that arachidonic acid in-
duces ERK [8] and JNK [15] phosphorylation in rabbitATF-2 as a substrate as described previously [15].
proximal tubular epithelial cells. The present study
Immunoblot assay for phosphorylated ERKs, p38MAPK, shows that arachidonic acid induced p38MAPK activity and
and MKK3/MKK6 phosphorylation in a time-dependent manner with a
maximum effect at 1 minute and returning to almostCell lysates were prepared (as described previously in
this article) following treatment. Proteins (15 mg) were basal levels by 15 minutes (Fig. 2 A and C, respectively).
In addition, arachidonic acid-induced p38MAPK activityseparated by SDS-PAGE on 10% (wt/vol) polyacryl-
amide gels and then transferred to a polyvinylidene and phosphorylation was found to be dose dependent,
and was significant at 5 mmol/L with a maximal effectdifluoride membrane by electroblotting at 200 mA for
1.5 hours. The membranes were blocked with 5% fat- at 15 mmol/L (Fig. 2 B and E, respectively).
Various studies have demonstrated that in mammalianfree dry milk in Tris-buffered saline (50 mmol/L Tris,
pH 8.0, 150 mmol/L NaCl) with 0.01% Tween 20 (TBS/T) cells, the MAPK superfamily is activated by various stim-
uli such as UV exposure [1, 2]. We recently demonstratedfor one hour at room temperature. Blots were then
washed three times in TBS/T and then incubated over- in proximal tubular epithelial cells that UV irradiation
induces phosphorylation of JNK [15]. With this in mind,night with primary antibodies at 1:1000 dilution in 3%
bovine serum albumin (BSA) TBS/T. After washing with our current study examined whether UV irradiation in-
duced phosphorylation of p38MAPK in rabbit proximal tu-TBS/T solution, blots were further incubated for one
hour at room temperature with goat anti-rabbit antibody bular epithelial cells. As shown in Figure 3A, UV irradia-
tion produced phosphorylation of p38MAPK that wasconjugated to horseradish peroxidase (Calbiochem, La
Jolla, CA, USA) at 1:2000 dilution in TBS/T. Blots were significant at 1 minute, but unlike arachidonic acid, it
was maximal at 20 minutes.washed four times in TBS/T before visualization. An
enhanced chemiluminescence (ECL) kit (Amersham, The MAPKs are activated by distinct upstream MAPK
kinases (MEK/MKK). Specifically, MEK1/MEK2 selec-Arlington Heights, IL, USA) was used for detection.
tively phosphorylates and activates the ERK subgroup
Measurement of arachidonic acid release [6, 20], whereas SEK1/MKK4 activates both JNK and
p38MAPK [2, 21]. MKK3/MKK6 specifically activate p38MAPKFirst-passage proximal tubule cells were grown in 12-
well plates in standard growth medium for 24 hours and [2]. To verify whether MKK3/MKK6 are involved in
arachidonic acid- and UV-induced phosphorylation ofsubsequently serum restricted for 48 hours. Cells were
incubated in serum-free DMEM containing [3H]-arachi- p38MAPK in rabbit proximal epithelial cells, MKK3/MKK6
phosphorylation was measured by Western blot assaydonic acid (1 mCi/mL) for four hours at 378C. The media
were removed, and the cells were then washed three using an anti-phospho-MKK3/MKK6 antibody. Arachi-
donic acid induced MKK3/MKK6 phosphorylation in atimes with 1 mL of DMEM containing 0.1% BSA. Fresh
serum-free DMEM was added containing agonist or ve- time-dependent manner with a maximal effect at one
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Fig. 2. Time course and dose response of p38MAPK activation and p38MAPK and MKK3/MKK6 phosphorylation by arachidonic acid in rabbit proximal
tubular cells. Serum-starved proximal tubular cells were treated with 10 mmol/L arachidonic acid for the indicated times or incubated with various
concentrations of arachidonic acid for one minute. Cells were lyzed, and extracts were immunoprecipitated with anti-p38MAPK antibody and then
used in kinase assays with ATF2 as a substrate (A and B), or used for Western blotting, with anti-phospho-p38MAPK antibody (C and E) or with
anti-phospho-MKK3/MKK6 antibody (D and F ) as a probe. Activity is expressed as a percentage of control. The results represents the mean 6
SEM of four independent experiments. Statistical comparisons were made with a one-way ANOVA followed by Newman–Keul’s comparisons
test. ***P , 0.001; **P , 0.01 vs. unstimulated control. The autoradiographs represent the results of a single experiment that was carried out at
least four times.
minute (Fig. 2D). Arachidonic acid-induced MKK3/ HPLC analysis of cytochrome P450-dependent
arachidonic acid metabolism in proximal tubule cellsMKK6 phosphorylation was found to be dose dependent
and was significant at 1 mmol/L but maximal at 15 mmol/L To demonstrate an active role for cytochrome P450
(Fig. 2F). By comparison, UV irradiation produced phos- isozymes in the metabolism of arachidonic acid in cul-
phorylation of MKK3/MKK6 that was significant at 1 tured rabbit proximal tubule cells, cells were transfected
minute but maximal at 20 minutes (Fig. 3B). Taken all with either cytochrome P450 2C1 or 2C2 isozymes, and
together, these findings suggest a signal mechanism exists reverse-phase HPLC analysis was performed following
for arachidonic acid- and UV-induced p38MAPK activation incubation with [14C]-arachidonic acid and extraction of
involving activation of MKK3/MKK6. Moreover, in both samples. Individual metabolites were not identified in
circumstances, either via kinase activity assay or direct the current study; however, EETs and HETEs were iden-
phosphorylation analysis, maximal p38MAPK and MKK3/ tified by coelution with authentic standards. As shown
MKK6 phosphorylation was more rapid following ara- in Figure 4C, cells transfected with the P450 2C1 isozyme
and stimulated with arachidonic acid (15 mmol/L) pro-chidonic acid as compared with UV irradiation.
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ERK activity by 228, 282, and 307% (P , 0.001) in
mock-, 2C1-, and 2C2-transfected cells, respectively, as
compared with basal levels (Fig. 5A and Table 1). Ara-
chidonic acid significantly increased JNK activity by 144,
136, and 146% (P , 0.001) in mock-, 2C1-, and 2C2-
transfected cells, respectively, as compared with basal
levels (Fig. 5B and Table 1). In comparison, p38MAPK
activation was significantly increased by 119, 153, and
Fig. 3. Effects of ultraviolet (UV) irradiation on p38MAPK and MKK3/ 181% (P , 0.001) in mock-, 2C1-, and 2C2-transfected
MKK6 phosphorylation in rabbit proximal tubular cells. Serum-starved
cells, respectively, as compared with basal levels (Fig. 5Cproximal tubular cells were treated with no stimulus or UV irradiation
(160 J/cm2) and were incubated for the indicated times at 378C. Cells and Table 1). These data demonstrate that endogenous
were lyzed and extracts were used for Western blotting. The blots were EETs and HETEs augment ERK and p38MAPK—but not
probed with either anti-phospho-p38MAPK antibody (A) or anti-phospho-
JNK—activity. Moreover, it demonstrates that arachi-MKK3/MKK6 antibody (B). The autoradiograph shows a representa-
tive Western blot. Essentially identical results were obtained in another donic acid is more potent than EETs and HETEs in
three experiments. activating these kinases.
Effects of cytochrome P450 inhibitors on arachidonic
acid-induced ERK and p38MAPK activation
duced primarily EETs (27 6 1% of total metabolites
First, the specificity of ketoconazole, a commonly usedformed, N 5 3), whereas the predominant metabolites
cytochrome P450 inhibitor, was evaluated by ascertain-following transfection with the 2C2 isozyme and stimula-
ing whether it inhibited the metabolites of arachidoniction with arachidonic acid (15 mmol/L) were also EETs
acid generated endogenously by cytochrome P450 2C1(23 6 2% of total metabolite formed, N 5 3); in addition,
and 2C2, and whether it blocked arachidonic acid- andsmall amounts of HETEs (6 6 0.8% of total metabolite
cytochrome P450 2C1- and 2C2-induced ERK activation.formed, N 5 3) were also produced (Fig. 4E). In contrast,
Pre-incubation of the proximal tubular cells with 30these products were undetectable in our unstimulated
mmol/L ketoconazole inhibited the cytochrome P450 iso-and arachidonic acid-stimulated cells transiently express-
zymes, thereby abolishing EET and HETE productioning pCMV5 with no insert cDNA (mock transfection;
(Fig. 4 D and F, respectively). In addition, 30 mmol/LFig. 4 A and B, respectively). The formation of cyclooxy-
ketoconazole significantly attenuated ERK activity in
genase and/or lipoxygenase products was not detectable
2C1- (124 vs. 156% of basal value, P , 0.05) and 2C2-
under any experimental condition in these epithelial transfected cells (127 vs. 192% of basal value, P , 0.01;
cells. Table 1). Ketoconazole alone did not significantly alter
basal ERK activity in mock-transfected cells. Ketocona-Role of cytochrome P450 isozymes in arachidonic
zole did not block the effects of arachidonic acid on 2C1-acid-induced MAPK activation
and 2C2-induced ERK activation. In fact, ketoconazole
Our previous studies documented that arachidonic actually potentiated the effects of arachidonic acid (414
acid mediates Ang II-induced ERK1/ERK2 and JNK vs. 328% of control value, P , 0.01) in mock-transfected
activation in proximal tubular epithelium [8, 15]. How- cells (Table 1). Second, we determined whether ketoco-
ever, the extent to which the oxidation of arachidonic nazole blocked the direct effects of v-hydroxylase and
acid to epoxygenase and v-hydroxylase products is re- epoxygenase products of arachidonic acid on ERK activ-
quired was not clarified. To elucidate the role of cyto- ity. As shown in Figure 6, arachidonic acid (15 mmol/L)
chrome P450 isozymes in arachidonic acid-induced significantly increased ERK activity by 264% (P , 0.001)
MAPK activation, we first evaluated whether overex- as compared with control. In addition, both 14,15-EET
pression of these isozymes could affect basal MAPK and 19-HETE significantly increased ERK activity by
activity. Figure 5A and Table 1 show that transfection 146 (P , 0.001) and 124% (P , 0.001), respectively,
with cytochrome P450 2C1 and 2C2 isozymes signifi- as compared with control. Ketoconazole (30 mmol/L)
cantly augmented basal ERK activity by 56 and 92% inhibited 36% (P , 0.001) and 29% (P , 0.01) of the
(P , 0.001), respectively, as compared with basal mock- 14,15-EET- and 19-HETE-induced ERK activation, re-
transfected cells. The 2C1 isozyme had no effect on basal spectively, as compared with control values. In contrast,
p38MAPK activity, whereas the 2C2 isozyme significantly 30 mmol/L ketoconazole augmented the arachidonic
augmented basal p38MAPK activity by 65% (P , 0.05), as acid-induced activation of ERK by 13% as compared
compared with basal mock-transfected cells (Fig. 5C and with control.
Table 1). In contrast, there was no significant effect of Next, to assess further whether v-hydroxylase and ep-
transfection of either isozyme on basal JNK activity (Fig. oxygenase products of arachidonic acid act as modulators
of arachidonic acid induced-ERK and p38MAPK phosphor-5B and Table 1). Arachidonic acid significantly increased
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Fig. 4. Arachidonic acid metabolism by rabbit P450 2C1 and 2C2 iso-
forms. Reverse-phase high-performance liquid chromatography (RP-
HPLC) chromatograms of [14C]arachidonic acid cytochrome P450-depen-
dent metabolism formed by rabbit proximal tubule cells transfected
with renal P450 2C1 and 2C2 isozymes. Empty vector (pCMV5)-trans-
fected and cytochrome P450 2C1 and 2C2-transfected rabbit proximal
tubular cells were made quiescent with serum-free medium for 24 hours.
Proximal tubule cells transfected with either empty vector (mock; A
and B) or P450 2C1 (C and D) or 2C2 (E and F ) isozymes were
preincubated in the presence (D and F) or absence (A–C and E) of 30
mmol/L ketoconazole for 30 minutes at 378C and then treated either
without (A) or with (B–F) 15 mmol/L arachidonic acid for 5 minutes
at 378C. Metabolites were extracted and separated by RP-HPLC as
described in the Methods section. The regions of elution for v/v-1-
hydroxylated (HETEs) and epoxygenated (EETs) metabolites are indi-
cated. Peak identifications were made by comparisons of HPLC proper-
ties of individual peaks with those of authentic standards.
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of the cells with 10 mmol/L 17-ODYA, a potent inhibitor
of both v-hydroxylase and epoxygenase enzyme activity
[22]. In addition, either pretreatment of proximal tubular
cells with 50 mmol/L PPOH, a selective epoxygenase
inhibitor, or with 10 mmol/L DDMS, a selective v-hydrox-
ylase inhibitor [22], did not affect arachidonic acid-in-
duced ERK and p38MAPK phosphorylation (Fig. 8). Thus,
the fact that arachidonic acid-induced ERK and p38MAPK
activation was not significantly altered in the presence
of ketoconazole and the specific cytochrome P450 inhibi-
tor 17-ODYA, as well as in the presence of the selective
epoxygenase and v-hydroxylase inhibitors PPOH and
DDMS, indicates that arachidonic acid-induced ERK
and p38MAPK activation is independent of eicosanoid bio-
synthesis. Moreover, ketoconazole appears to be a non-
selective inhibitor of the cytochrome P450-dependent
arachidonic acid metabolic pathway, since it inhibits
ERK activity induced by selected products, albeit to a
small degree.
Effects of cytochrome P450-dependent arachidonic
acid metabolites on MAPK activity
To compare the roles of the two classes of cytochrome
P450 metabolites more directly, we examined the effects
of epoxy (EETs)- and v-/v-1-hydroxy (HETEs)-deriva-
tives of arachidonic acid on MAPK activation. As shown
in Figure 9A, 15 mmol/L of the four epoxides, as well as
19- and 20-HETEs, significantly increased ERK activity,
with 14,15-EET (246% above control value, P , 0.001)
and 19- and 20-HETEs (255 and 247% above control
value, respectively, P , 0.001) being the most potent. An
equimolar concentration of arachidonic acid increased
ERK by 264% (P , 0.001) as compared with control. The
19- and 20-HETE significantly increased JNK activity by
108 and 113% (P , 0.01), respectively, as compared with
control. An equimolar concentration of arachidonic acid
increased JNK by 210% (P , 0.001) as compared with
Fig. 5. Role of cytochrome P450 isozymes in arachidonic acid-induced control. The epoxides were without any effect (Fig. 9B).
MAPK activation. Proximal tubule cells were transfected with P450 Three of the four epoxides (except for 11,12-EET) and2C1 and 2C2 isozymes and then incubated either in the presence (j)
19- and 20-HETEs significantly increased p38 MAPK activ-or absence (h) of arachidonic acid (A) ERK, 15 mmol/L for 5 min; (B)
JNK, 30 mmol/L for 15 min; and (C) p38MAPK, 10 mmol/L for 1 min at ity, with the EETs being more potent than the HETEs
378C. Cells were lyzed. ERK was immunoprecipitated, and its activity (Fig. 9C). Again, arachidonic acid was more potent thanwas detected as myelin basic protein (MBP) phosphorylation. JNK and
the EETs and HETEs, increasing p38 MAPK activity byp38MAPK were immunoprecipitated, and their activity was detected as
ATF-2 phosphorylation. Activity is expressed as a percentage of control. 194% (P , 0.001) as compared with control. These re-
The results represents the mean 6 SEM of at least three to five separate sults demonstrate that ERK and p38MAPK activity is stimu-experiments. Statistical comparisons were made with a one-way analysis
lated via the epoxygenation and v-hydroxylation of ara-of variance followed by Newman–Keul’s comparisons test. ***P ,
0.001; **P , 0.01; *P , 0.05 vs. (basal) mock-transfected cells; #P , chidonic acid, whereas JNK activity is stimulated only
0.001 vs. unstimulated same-matched cells The mock refers to cells by the v-hydroxylation of arachidonic acid and only totransfected with the empty vector (pCMV5) alone.
a minimal degree. Moreover, these results suggest that
arachidonic acid itself, and not its cytochrome P450-
dependent metabolites, is the direct effector of MAPKylation, additional inhibitors of the cytochrome P450-
dependent arachidonic acid metabolic pathway were activation in renal proximal tubule cells.
We next examined whether eicosanoids and arachi-used. Figure 7 demonstrates that arachidonic acid pro-
duced significant increases in the phosphorylation of donic acid act through similar upstream activators to
mediate p38MAPK phosphorylation. Figure 10B shows thatERK and p38MAPK that were not altered by pretreatment
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Table 1. Effects of cytochrome P450 inhibition on arachidonic acid- and P450 2C1- and 2C2-induced
extracellular signal-regulated kinase (ERK) activation
Ketoconazole 1
Basal Arachidonic acid Ketoconazole arachidonic acid
Mock 100 328.00638.76b 114.5066.38 414.00620.62e
pCMV 2C1 156.40612.78a 382.20626.52b 124.75611.97d 421.75636.95
pCMV 2C2 192.40616.50a 407.00623.12b 127.7568.80c 409.00619.02
Cytochrome P450 2C1 and 2C2 and empty vector (pCMV5)-transfected cells were made quiescent with serum-free medium for 24 hours and pretreated either
with or without ketoconazole (30 mmol/L) for 30 minutes, and stimulated with or without arachidonic acid (15 mmol/L) for 5 minutes. Cells were lysed and then
used in ERK kinase assay with MBP as a substrate. The mock refers to cells transfected with the empty vector (pCMV5). One-way ANOVA followed by Newman-
Keul’s comparisons test (N 5 3–5 experiments).
a P , 0.001 vs. unstimulated mock-transfected cells
b P , 0.001, c P , 0.01, d P , 0.05 vs. unstimulated same-matched cells
e P , 0.01 vs. arachidonic acid-stimulated cells
Fig. 6. Effects of ketoconazole on cytochrome
P450-arachidonic acid metabolism in proximal
tubular epithelial cells. Quiescent rabbit prox-
imal tubular epithelial cells were preincubated
with 30 mmol/L ketoconazole for 30 minutes
before exposure to 15 mmol/L of arachidonic
acid, 14,15-EET, and 19-HETE for 5 minutes
at 378C. Cells were lyzed. ERK was immuno-
precipitated, and its activity was detected as
myelin basic protein (MBP) phosphorylation.
Activity is expressed as a percentage of con-
trol with unstimulated as 100%. Symbols are:
(h) no ketoconazole; (j) plus ketoconazole.
The results represent the mean 6 SEM of four
separate experiments. Statistical comparisons
were made with a one-way ANOVA followed
by Newman–Keuls multiple comparison test.
***P , 0.001 vs. unstimulated control or
111P , 0.001; 11P , 0.01; 1P , 0.05 vs.
agonist-stimulated same-matched cells. The
autoradiographs represent the results of a sin-
gle experiment that was carried out at least
four times.
equimolar concentrations of arachidonic acid, 14,15- dent of eicosanoid biosynthesis, we evaluated whether
other fatty acids with different chain lengths and degreesEET, and 19-HETE all led to MKK3/MKK6 phosphory-
of saturation have an effect on MAPK activation. Figurelation, suggesting that MKK3/MKK6 may mediate both
11 A and B show that the two polyunsaturated fattyarachidonic acid- and eicosanoid-induced p38MAPK phos-
acids, linoleic (C18:2) and linolenic (C18:3), significantlyphorylation.
increased ERK activity by 335% (P , 0.01) and 274%
Fatty acid activation of MAPK (P , 0.05) and JNK activity by 125% (P , 0.01) and
85% (P , 0.01), respectively, as compared with control.Since the previously mentioned observations suggest
that arachidonic acid directly activates MAPK indepen- In comparison, linoleic acid significantly increased
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Fig. 7. Effects of 17-octadecynoic acid (17-ODYA) on arachidonic acid
induced-ERK and p38MAPK activation. Serum-starved proximal tubular
cells were pretreated either without or with 10 mmol/L 17-ODYA for Fig. 8. Cytochrome P450 inhibitors do not inhibit arachidonic acid-
15 minutes and then incubated in the presence or absence of arachidonic induced ERK and p38MAPK activation. Serum-starved proximal tubular
acid (A) ERK (15 mmol/L, 5 min) and (B) p38MAPK (10 mmol/L, 1 min) cells were pretreated either with or without PPOH (50 mmol/L) or
at 378C. Cells were lyzed, and extracts were used for Western blotting. DDMS (10 mmol/L) for 15 minutes and then incubated in the presence
The blots were probed with either rabbit polyclonal anti-phospho- or absence of arachidonic acid (A) ERK (15 mmol/L, 5 min) and (B)
p44/p42MAPK antibody or and anti-phospho-p38MAPK antibody. The auto- p38MAPK (10 mmol/L, 1 min) at 378C. Cells were lyzed, and extracts were
radiograph shows a representative Western blot. Essentially identical used for Western blotting. The blots were probed with either rabbit
results were obtained in another three experiments. polyclonal anti-phospho-p44/p42MAPK antibody or and anti-phospho-
p38MAPK antibody. The autoradiograph shows a representative Western
blot. Essentially identical results were obtained in another three experi-
ments.
p38MAPK activity by 322% (P , 0.001) as compared with
control, whereas linolenic acid was without effect (Fig.
11C). The two monounsaturated fatty acids, oleic (C18:1) to augment arachidonic acid release and decreased label
and palmitoleic (C16:1), significantly increased ERK ac- release that was significant at 15 and 30 minutes (P ,
tivity by 188% (P , 0.05) and 212% (P , 0.05) as 0.05; Fig. 12). Thus, these data suggest that ETYA does
compared with control. In comparison, palmitoleic acid not compete with arachidonic acid for incorporation into
significantly increased JNK activity by 133% (P , 0.01) membrane phospholipids for MAPK activation in renal
as compared with control, whereas oleic acid was without proximal tubule epithelial cells. This consideration is
effect. In contrast, neither palmitoleic or oleic acid had especially important given the fact that equimolar con-
any effects on p38MAPK activation. The two saturated fatty centrations of arachidonic acid, ETYA, and other poly-
acids, stearic (C18) and arachidic (C20), appeared to unsaturated fatty acids, including three fatty acids that
have no effect on MAPK activation. Additional evidence are not substrates for cytochrome P450, cyclooxygenase,
for direct involvement of arachidonic acid in MAPK and lipoxygenase enzymes [linolenic acid (C18:3) and
activation, excluding the involvement of arachidonic acid the more saturated oleic acid (C18:1), and the shorter
metabolites, was obtained with ETYA, the nonmetabo- chain, palmitoleic acid (C16:1)], all induced MAPK acti-
lizable analogue of arachidonic acid, which blocks arachi- vation, thus providing convincing evidence for a direct
donic acid metabolism by acting as a false substrate involvement of arachidonic acid and other fatty acids in
[23, 24]. The addition of ETYA significantly increased MAPK activation in proximal tubular epithelium.
ERK, JNK, and p38MAPK activity by 199% (P , 0.01; Fig.
11A), 129% (P , 0.01; Fig. 11B), and 448% (P , 0.001;
DISCUSSIONFig. 11C), respectively, as compared with controls. In
addition to its ability to compete with arachidonic acid Mitogen-activated protein kinases are activated by
various extracellular stimuli [1–6]. We have demon-for activation, ETYA has been reported to inhibit arachi-
donic acid incorporation into cells membrane lipids via strated that arachidonic acid-induces phosphorylation of
JNK and ERK, two members of the MAPK superfamily,its ability to compete with arachidonic acid for uptake
and esterification enzymes, thereby being itself incorpo- in rabbit proximal tubular epithelial cells [8, 14, 15].
The present study found that arachidonic acid stimulatedrated into cell lipids [25–27]. Therefore, we determined
the effects of ETYA on arachidonic acid release in rabbit p38MAPK activity, a third member of the MAPK superfam-
ily, and MKK3/MKK6 phosphorylation (its upstream ac-proximal tubular cells. In contrast to AngII, ETYA failed
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Fig. 10. Effects of cytochrome P450-dependent arachidonic acid me-
tabolites on p38MAPK and MKK3/MKK6 phosphorylation. Serum-starved
proximal tubular cells were treated with either arachidonic acid, 14,15-
EET, or 19-HETE (15 mmol/L, 1 min) at 378C. Cells were lyzed, and
extracts were used for Western blotting. The blots were probed with
either rabbit polyclonal anti-phospho-p38MAPK antibody (A) or a rabbit
polyclonal anti-phospho-MKK3/MKK6 antibody (B). The autoradio-
graph shows a representative Western blot. Essentially identical results
were obtained in another three experiments.
tivator) in a time- and concentration-dependent manner.
In addition, this study is the first to our knowledge to
compare the relative potency of P450 products (exoge-
nous and endogenous) as mediators of various members
of the MAPK superfamily. We observed that arachidonic
acid was generally more potent than the individual ep-
oxygenase or v-hydroxylase products on a molar basis
as an activator of all three members of MAPK. Specifi-
cally, the EETs were found to be more potent activators
of ERKs as compared with JNK and p38MAPK, whereas
only HETEs activated JNK. The superior potency of
arachidonic acid as compared with its cytochrome P450
monooxygenase products parallels earlier studies on reg-
ulation of Ca21 influx through a voltage-sensitive Ca21
channel in rabbit proximal tubule. In that study, 5,6-
EET was found to be the most potent of the regioisomers
[28], unlike the current study in which 14,15-EET and
b
Fig. 9. Effects of cytochrome P450-dependent arachidonic acid metab-
olites on MAPK activity. Proximal tubule cells were stimulated either
with or without the appropriate agonist (A) ERK (15 mmol/L, 5 min),
(B) JNK (30 mmol/L, 15 min), and (C) p38MAPK (15 mmol/L, 1 min) at
378C. Cells were lyzed. ERK was immunoprecipitated, and its activity
was detected as myelin basic protein (MBP) phosphorylation. JNK
and p38MAPK were immunoprecipitated, and its activity was detected as
ATF-2 phosphorylation. Activity is expressed as a percentage of control,
with unstimulated as 100%. The results represents the mean 6 SEM
of at least three to five separate experiments. Statistical comparisons
were made with a one-way ANOVA followed by Newman–Keuls multi-
ple comparison test. ***P , 0.001; **P , 0.01; *P , 0.05 vs. control.
The autoradiographs represent the results of a single experiment that
was carried out at least three times. Symbols are: (h) control; (j)
arachidonic acid; ( ) 5,6-EET; ( ) 8,9-EET; ( ) 11,12-EET; ( )
14,15-EET; ( ) 19-HETE; ( ) 20-HETE.
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19-HETE and 20-HETE were more potent than the oth-
ers. The effects of arachidonic acid on activation of the
MAPK superfamily appeared to be specific and not re-
quire arachidonic acid metabolism via the cytochrome
P450-dependent monooxygenase pathway for several
reasons: (1) the ineffectiveness of ketoconazole, 17-
ODYA, PPOH, and DDMS to inhibit arachidonic acid-
induced ERK and p38MAPK activation; and (2) the lack
of superior potency of exogenous or endogenous mono-
oxygenase products. More evidence in support of specific
fatty acid-mediated signaling was gained through the
use of other fatty acids with different chain lengths and
degrees of saturation. Linoleic acid (C18:2), which is
a potential substrate for oxygenases, was effective at
stimulating ERK, JNK, and p38MAPK activities, however,
with less potency than arachidonic acid. ERK was acti-
vated by two additional fatty acids that are not substrates
for these enzymatic pathways, linolenic acid (C18:3) and
the more saturated oleic acid (C18:1), as well as by the
monounsaturated fatty acid palmitoleic acid (C16:1). Pal-
mitoleic acid also stimulated JNK while having no effect
on p38MAPK. On the other hand, oleic acid failed to acti-
vate either JNK or p38MAPK. The two saturated fatty acids,
stearic (C18) and arachidic (C20), failed to activate any
of these MAP kinases. ETYA, the nonmetabolizable
analogue of arachidonic acid that inhibits arachidonic
acid uptake [25–27], induced ERK, JNK, and p38MAPK
activation, as well as inhibiting arachidonic acid release
from these proximal tubular cells. Our data demonstrate
that arachidonic acid and other fatty acids activate mem-
bers of the MAPK superfamily directly in proximal tu-
bule epithelium and function independently of being me-
tabolized to products of the cytochrome P450 pathway.
Moreover, the observations that P450 products are gen-
erally less potent than arachidonic acid, the lack of effects
of specific inhibitors, and the potency of inactive arachi-
donic analogues and other fatty acids raises questions
that cytochrome P450 products are obligate intermedi-
ates in this signaling pathway in kidney epithelial cells.
It is unlikely that inhibition of the cytochrome P450
pathways shunts arachidonic acid metabolism down an
alternative pathway leading, for example, to cyclooxy-
genase and/or lipoxygenase products, resulting in MAPK
activation. In this respect, we have consistently demon-
strated undetectable levels of these products in our prox-
Fig. 11. Fatty acid activation of MAPK. A variety of fatty acids (A) imal tubule cells. Furthermore, studies by our laboratory
ERK (15 mmol/L, 5 min), (B) JNK (30 mmol/L, 15 min), and (C) p38MAPK examined the effects of inhibitors on the MAPK pathway
(10 mmol/L, 1 min) were examined for their effectiveness in MAPK
and found that the cyclooxygenase inhibitor indometha-activation in proximal tubular epithelial cells. Quiescent rabbit proximal
tubular epithelial cells were exposed to either arachidonic acid (C20:4),
ETYA (C20:4), linoleic acid (C18:2), linolenic acid (C18:3), oleic acid
(C18:1), palmitoleic acid (C16:1), stearic acid (C18), or arachidic acid
(C20) for indicated times at 378C. The number in parentheses indicate
the carbon chain length followed by the number of double bonds. Cells sents the mean 6 SEM of four separate experiments. Statistical compari-
were lyzed. ERK was immunoprecipitated, and its activity was detected sons were made with a one-way ANOVA followed by the Newman–
as myelin basic protein (MBP) phosphorylation. JNK and p38MAPK were Keuls multiple comparison test. ***P , 0.001; **P , 0.01; *P , 0.05
immunoprecipitated, and its activity was detected as ATF-2 phosphory- vs. unstimulated control. The autoradiographs represent the results of
lation. Activity is expressed as percentage of control. The results repre- a single experiment which was carried out at least four times.
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Fig. 12. Time course of Ang II- and ETYA-
stimulated release of arachidonic acid. Quies-
cent rabbit proximal tubular epithelial cells
were prelabeled with [3H]-arachidonic acid
(1 mCi/mL) for four hours and then treated
with either media alone (j) or with media sup-
plemented with [Sar1]-Ang II (1 mmol/L; )
or ETYA (15 mmol/L; ) for different time
intervals as described in the Methods section.
Values (mean 6 SEM, N 5 9) represent the
differences between treatments and control
at each time interval. Statistical comparisons
were made with a Student paired t test. *P ,
0.05 vs. control; ***P , 0.001.
cin had no effect on arachidonic acid-induced ERK phos- linoleic acid stimulated JNK activity independent of their
metabolism through either cyclooxygenase, lipoxygen-phorylation [8]. In addition, neither indomethacin nor
the lipoxygenase inhibitor cinnamyl-3,4-dihydroxy-cya- ase, or cytochrome P450 monooxygenase pathways [4, 5].
However, all of these studies were limited to the use ofnocinnamate (CDC) inhibited arachidonic acid-induced
JNK activation [15]. In fact, we demonstrated that other inhibitors that were nonspecific for the various pathways.
In several studies, Chen et al similarly studied arachi-arachidonic acid metabolites, including some lipoxygen-
ase (5-, 12- and 15-HETE), as well as cyclooxygenase donic acid signaling in LLCPK1 cells and reported that
arachidonic acid was ineffective in inducing ERK phos-(leukotrienes B4 and C4) products had no effect on
MAPK phosphorylation in proximal tubule epithelial phorylation; however, arachidonic acid produced sig-
nificantly increases in ERK phosphorylation in F87V BM-cells [8]. Together, these observations suggest that the
only requirement for activation of MAPKs by arachi- 3–transfected cells [regioselective and strereoselective
for 14(S), 15(R)-EET] that was inhibited by 17-ODYA,donic acid is arachidonic acid itself.
Observations that most closely mimic the studies de- whereas no such effects were observed in vector-trans-
fected cells [33, 34]. Their experimental results suggestedscribed herein were obtained employing liver epithelial
white blood (WB) cells whereby arachidonic acid, 20:4(n-6) an eicosanoid-dependent activation of ERK in LLCPK1
cells. This is in stark contrast to our studies where signifi-and the two polyunsaturated fatty acids [PUFA; eicosa-
pentaenoic acid, 22:6(n-3) and docosahexaenoic acid, cant increases in ERK activity were consistently ob-
served with exogenous arachidonic acid independent of22:6(n-3)] activated ERK independent of downstream
metabolism [29]. Studies employing vascular smooth eicosanoid biosynthesis. Moreover, Chen et al reported
that 14,15-EET concentrations of 30 mmol/L were re-muscle cell lines demonstrated that 20-HETE increased
the activities of ERK and that arachidonic acid and lino- quired in order to stimulate ERK phosphorylation
[33, 34], whereas we obtained such a response with onlyleic acid activated ERK by a mechanism that was depen-
dent on cytochrome P450 monooxygenase and lipoxy- 15 mmol/L 14,15-EET. In fact, we demonstrated activa-
tion of ERKs by arachidonic acid that was detectable atgenase pathways, whereas JNK activation did not [30–32].
Similar to our study, utilizing rat mesangial and stroma concentrations as low as 1.5 mmol/L [18]. These differ-
ences between the two reports may be due to differencescell lines, it was demonstrated that arachidonic acid and
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in either culture conditions or cell type specificity. To- signaling linked to the MAPK superfamily in kidney
epithelium, whereby arachidonic acid-induced MAPKgether, these observations demonstrate a diversity of ara-
chidonic acid effects regarding the regulation of MAPK phosphorylation is direct and independent of cyto-
chrome P450 metabolism.phosphorylation that can involve either a direct effect
by arachidonic acid itself or an eicosanoid-dependent
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APPENDIXwas identical in the presence or absence of transfected
isozymes. Therefore, neither 2C1 nor 2C2 transfection Abbreviations used in this article are: Ang II, angiotensin II; AT2,
angiotensin II subtype 2 (receptor); ATP, adenosine 59-triphosphate;augmented the ability of arachidonic acid to induce acti-
C16:1, palmitoleic fatty acid; C18, stearic fatty acid; C18:1, oleic fatty
vation of ERK, JNK, or p38MAPK. acid; C18:2, linoleic acid C18:3, linolenic acid; C20, arachidic fatty acid;
CDC, cinnamyl-3,4-dihydroxy-cyanocinnamate; DDMS, N-methyl-In summary, the present studies demonstrate that cy-
sulfonyl-12,12-dibromododec-11-enamide; DMEM, Dulbecco’s modi-tochrome P450 2C1 and 2C2 isozymes are mediators of
fied Eagle’s medium; ECL, enhanced chemiluminescence; EET, epoxy-
MAPK activation in rabbit proximal tubular epithelial eicosatrienoic acid; EGF, epidermal growth factor; ERK, extracellular
signal-regulated kinase; ETYA, eicosatetraynoic acid; GPCRs, G-proteincells. In general, EETs are more potent activators of
coupled receptors; GTP, guanosine triphosphate; HETE, hydroxyepoxy-ERK as compared with JNK and p38MAPK. EETs and
eicosatrienoic acid; HPLC, high pressure liquid chromotography; IL,
HETEs activate ERK and p38MAPK, while only HETEs interleukin; JNK, c-Jun NH2-terminal kinase; MAPK, mitogen-acti-
activate JNK. Particularly novel is the fact that arachi- vated protein kinase; MBP, myelin basic protein; NDGA, nordihydro-
guaiaretic acid; 17-ODYA, 17-octadecynoic acid; PKC, protein kinasedonic acid, when directly compared, was generally more
C; PLA, phospholipase A; PPOH, 6-(2-propargloxyphenyl)hexanoicpotent than the individual metabolites on a molar basis. acid; PUFA, polyunsaturated fatty acid; SDS-PAGE, sodium dodecyl
Supporting data derived from the facts that ketoconazole sulfate-polyacrylamide gel electrophoresis; TBS/T, Tris-buffered sa-
line/Tween 20; TNF, tumor necrosis factor; UV, ultraviolet.and the more potent cytochrome P450 inhibitor 17-ODYA,
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